Prebiotics and Probiotics in Digestive Health

被引:231
作者
Quigley, Eamonn M. M. [1 ,2 ]
机构
[1] Houston Methodist Hosp, Div Gastroenterol & Hepatol, Lynda K & David M Underwood Ctr Digest Disorders, Houston, TX USA
[2] Weill Cornell Med Coll, Houston, TX USA
关键词
Microbiota; Probiotic; Prebiotic; Synbiotics; IRRITABLE-BOWEL-SYNDROME; BIFIDOBACTERIUM-INFANTIS; 35624; INTERNATIONAL SCIENTIFIC ASSOCIATION; INDUCED VISCERAL HYPERSENSITIVITY; CLOSTRIDIUM-DIFFICILE INFECTION; LACTIC-ACID BACTERIA; GUT-BRAIN AXIS; LACTOBACILLUS-REUTERI; CONSENSUS STATEMENT; EPITHELIAL-CELLS;
D O I
10.1016/j.cgh.2018.09.028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
As the importance of the gut microbiota in health and disease is increasingly recognized interest in interventions that can modulate the microbiota and its interactions with its host has soared. Apart from diet, prebiotics and probiotics represent the most commonly used substances taken in an effort to sustain a healthy microbiome or restore balance when it is believed bacterial homeostasis has been disturbed in disease. While a considerable volume of basic science attests to the ability of various prebiotic molecules and probiotic strains to beneficially influence host immune responses, metabolic processes and neuro-endocrine pathways, the evidence base from human studies leaves much to be desired. This translational gap owes much to the manner in which this sector is regulated but also speaks to the challenges that confront the investigator who seeks to explore microbiota modulation in either healthy populations or those who suffer from common digestive ailments. For many products marketed as probiotics, some of the most fundamental issues relating to quality control, such as characterization, formulation, viability safety are scarcely addressed.
引用
收藏
页码:333 / 344
页数:12
相关论文
共 136 条
[1]   A Probiotic for Ulcerative Colitis: The Culture Wars Continue [J].
Abraham, Bincy P. ;
Quigley, Eamonn M. M. .
DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (07) :1678-1680
[2]   Probiotics in Inflammatory Bowel Disease [J].
Abraham, Bincy P. ;
Quigley, Eamonn M. M. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2017, 46 (04) :769-+
[3]   Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation [J].
Agrawal, A. ;
Houghton, L. A. ;
Morris, J. ;
Reilly, B. ;
Guyonnet, D. ;
Feuillerat, N. Goupil ;
Schlumberger, A. ;
Jakob, S. ;
Whorwell, P. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (01) :104-114
[4]   Effect of Lactobacilli on Paracellular Permeability in the Gut [J].
Ahrne, Siv ;
Hagslatt, Marie-Louise Johansson .
NUTRIENTS, 2011, 3 (01) :104-117
[5]   Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity:: a possible action through interaction with epithelial cell cytoskeleton contraction [J].
Ait-Belgnaoui, A. ;
Han, W. ;
Lamine, F. ;
Eutamene, H. ;
Fioramonti, J. ;
Bueno, L. ;
Theodorou, V. .
GUT, 2006, 55 (08) :1090-1094
[6]  
AlFaleh K, 2013, J Neonatal Perinatal Med, V6, P1, DOI 10.3233/NPM-1363712
[7]  
Alimentarius C., 2010, Guidelines on nutrition labelling cac/gl 2-1985 as last amended 2010
[8]   Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp longum 35624™ [J].
Altmann, Friedrich ;
Kosma, Paul ;
O'Callaghan, Amy ;
Leahy, Sinead ;
Bottacini, Francesca ;
Molloy, Evelyn ;
Plattner, Stephan ;
Schiavi, Elisa ;
Gleinser, Marita ;
Groeger, David ;
Grant, Ray ;
Perez, Noelia Rodriguez ;
Healy, Selena ;
Svehla, Elisabeth ;
Windwarder, Markus ;
Hofinger, Andreas ;
Motherway, Mary O'Connell ;
Akdis, Cezmi A. ;
Xu, Jun ;
Roper, Jennifer ;
van Sinderen, Douwe ;
O'Mahony, Liam .
PLOS ONE, 2016, 11 (09)
[9]  
[Anonymous], HLTH NUTR PROP PROB
[10]  
[Anonymous], PROB HLTH CLAIMS